全文获取类型
收费全文 | 4560篇 |
免费 | 333篇 |
国内免费 | 36篇 |
学科分类
医药卫生 | 4929篇 |
出版年
2023年 | 25篇 |
2022年 | 35篇 |
2021年 | 137篇 |
2020年 | 89篇 |
2019年 | 124篇 |
2018年 | 143篇 |
2017年 | 117篇 |
2016年 | 132篇 |
2015年 | 129篇 |
2014年 | 171篇 |
2013年 | 229篇 |
2012年 | 345篇 |
2011年 | 335篇 |
2010年 | 197篇 |
2009年 | 161篇 |
2008年 | 254篇 |
2007年 | 267篇 |
2006年 | 228篇 |
2005年 | 238篇 |
2004年 | 224篇 |
2003年 | 201篇 |
2002年 | 188篇 |
2001年 | 81篇 |
2000年 | 74篇 |
1999年 | 68篇 |
1998年 | 46篇 |
1997年 | 24篇 |
1996年 | 31篇 |
1995年 | 18篇 |
1994年 | 26篇 |
1993年 | 20篇 |
1992年 | 43篇 |
1991年 | 34篇 |
1990年 | 44篇 |
1989年 | 41篇 |
1988年 | 40篇 |
1987年 | 44篇 |
1986年 | 34篇 |
1985年 | 37篇 |
1984年 | 33篇 |
1983年 | 19篇 |
1982年 | 15篇 |
1981年 | 9篇 |
1979年 | 24篇 |
1978年 | 14篇 |
1974年 | 18篇 |
1973年 | 15篇 |
1971年 | 11篇 |
1970年 | 14篇 |
1969年 | 9篇 |
排序方式: 共有4929条查询结果,搜索用时 31 毫秒
81.
N Entz-Werle S Suciu J van der Werff ten Bosch E Vilmer Y Bertrand Y Benoit G Margueritte E Plouvier P Boutard E Vandecruys A Ferster P Lutz A Uyttebroeck C Hoyoux A Thyss X Rialland L Norton M-P Pages N Philippe J Otten C Behar 《Leukemia》2005,19(12):2072-2081
The first EORTC (European Organization of Research and Treatment of Cancer) acute myeloblastic leukemia (AML) pilot study (58872) was conducted between January 1988 and December 1991. Out of 108 patients, 78% achieved complete remission (CR), and event-free survival (EFS) and survival rates (s.e., %) at 7 years were 40 (5) and 51% (6%), respectively. It indicated that mitoxantrone could be substituted for conventional anthracyclines in the treatment of childhood AML without inducing cardiotoxicity. The aim of the next EORTC 58921 trial was to compare the efficacy and toxicity of idarubicin vs mitoxantrone in initial chemotherapy courses, further therapy consisting of allogeneic bone marrow transplantation (alloBMT) in patients with an HLA-compatible sibling donor or chemotherapy in patients without a donor. Out of 177 patients, recruited between October 1992 and December 2002, 81% reached CR. Overall 7-year EFS and survival rates were 49 (4) and 62% (4%), respectively. Out of 145 patients who received the first intensification, 39 had a sibling donor. In patients with or without a donor, the 7-year disease-free survival (DFS) rate was 63 (8) and 57% (5%) and the 7-year survival rate was 78 (7) and 65% (5%), respectively. Patients with favorable, intermediate and unfavorable cytogenetic features had a 5-year EFS rate of 57, 45 and 45% and a 5-year survival rate of 89, 67 and 53%, respectively. 相似文献
82.
Benoit R Watts DD Dwyer K Kaufmann C Fakhry S 《The Journal of trauma》2000,49(3):477-81; discussion 481-2
BACKGROUND: Falls from windows in urban areas cause a significant number of pediatric injuries. Window falls have not been well described in the nonurban setting. We describe the epidemiology of window falls from residential homes among pediatric patients at a suburban Level I trauma center. METHODS: A review of patients admitted from January 1991 through November 1999 to a center serving a rapidly growing suburban area was performed. RESULTS: A total of 2,322 children, ages 0-14 years, were admitted during the study period. Falls comprised 41% of these admissions, and 11% of falls were from windows, greater than twice the national average. More than 39% of children who fell from windows were admitted directly to the intensive care unit. Overall mortality rate was 4%. Ages 0 to 4 years comprised the largest percentage (83%), and all children who died were in this age group. Children < or = 4 years were more likely to have an Abbreviated Injury Score > or = 2 (head injury) than those ages 10 to 14 years (p = 0.032). More than 31% of all children injured in window falls seen at the study institution between 1991 and 1999 were admitted in the last 2 years. CONCLUSION: Pediatric falls from windows in this suburban area appear to be increasing, with an incidence greater than the national average. Children at greatest risk are less than 4 years old. Further research in injury prevention at the national level aimed at suburban areas may be warranted. 相似文献
83.
Marielle Ister M.D. Guillaume Pouessel M.D. Hubert Ythier M.D. Benoit Catteau M.D. Olivier Carpentier M.D. 《Pediatric dermatology》2014,31(4):e94-e95
Bullous pemphigoid is an autoimmune subepidermal blistering disorder that typically affects elderly adults but can also occur in childhood. We report on a 3‐month‐old boy who developed bullous pemphigoid 1 week after the second routine administration of a hexavalent vaccine. The disease was resistant to standard therapies (including oral and topical corticosteroids) but was relieved by intravenous immunoglobulin treatment. There was no recurrence of bullous pemphigoid after the next vaccination (3 mos after discontinuation of steroids). 相似文献
84.
Marius Sebastian Secula Igor Cretescu Benoit Cagnon Liliana Rozemarie Manea Corneliu Sergiu Stan Iuliana Gabriela Breaban 《Materials》2013,6(7):2723-2746
The aim of this study was to determine the effects of main factors and interactions on the color removal performance from dye solutions using the electrocoagulation process enhanced by adsorption on Granular Activated Carbon (GAC). In this study, a mathematical approach was conducted using a two-level fractional factorial design (FFD) for a given dye solution. Three textile dyes: Acid Blue 74, Basic Red 1, and Reactive Black 5 were used. Experimental factors used and their respective levels were: current density (2.73 or 27.32 A/m2), initial pH of aqueous dye solution (3 or 9), electrocoagulation time (20 or 180 min), GAC dose (0.1 or 0.5 g/L), support electrolyte (2 or 50 mM), initial dye concentration (0.05 or 0.25 g/L) and current type (Direct Current—DC or Alternative Pulsed Current—APC). GAC-enhanced electrocoagulation performance was analyzed statistically in terms of removal efficiency, electrical energy, and electrode material consumptions, using modeling polynomial equations. The statistical significance of GAC dose level on the performance of GAC enhanced electrocoagulation and the experimental conditions that favor the process operation of electrocoagulation in APC regime were determined. The local optimal experimental conditions were established using a multi-objective desirability function method. 相似文献
85.
E. N. Nyangoma C. K. Olson J. A. Painter D. L. Posey W. M. Stauffer M. Naughton W. Zhou M. Kamb S. R. Benoit 《Journal of immigrant and minority health / Center for Minority Public Health》2017,19(4):835-842
U.S. immigration regulations require clinical and serologic screening for syphilis for all U.S.-bound refugees 15 years of age and older. We reviewed syphilis screening results for all U.S.-bound refugees from January 1, 2009 through December 31, 2013. We calculated age-adjusted prevalence by region and nationality and assessed factors associated with syphilis seropositivity using multivariable log binomial regression models. Among 233,446 refugees, we identified 874 syphilis cases (373 cases per 100,000 refugees). The highest overall age-adjusted prevalence rates of syphilis seropositivity were observed among refugees from Africa (1340 cases per 100,000), followed by East Asia and the Pacific (397 cases per 100,000). In most regions, male sex, increasing age, and living in non-refugee camp settings were associated with syphilis seropositivity. Future analysis of test results, stage of infection, and treatment delivery overseas is warranted in order to determine the extent of transmission risk and benefits of the screening program. 相似文献
86.
87.
88.
89.
Andreas Schlitzer Naomi McGovern Pearline Teo Teresa Zelante Koji Atarashi Donovan Low Adrian W.S. Ho Peter See Amanda Shin Pavandip Singh Wasan Guillaume Hoeffel Benoit Malleret Alexander Heiseke Samantha Chew Laura Jardine Harriet A. Purvis Catharien M.U. Hilkens John Tam Florent Ginhoux 《Immunity》2013,38(5):970-983
90.
A cluster‐randomized controlled trial evaluating the effects of delaying onset of adolescent substance abuse on cognitive development and addiction following a selective,personality‐targeted intervention programme: the Co‐Venture trial
下载免费PDF全文
![点击此处可从《Addiction (Abingdon, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)